These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 647548)

  • 1. Estrogen use and cancer of the uterine corpus in Alberta.
    Wigle DT; Grace M; Smith ES
    Can Med Assoc J; 1978 May; 118(10):1276-8. PubMed ID: 647548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens and endometrial carcinoma.
    Gray LA; Christopherson WM; Hoover RN
    Obstet Gynecol; 1977 Apr; 49(4):385-9. PubMed ID: 193072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
    Cramer DW; Knapp RC
    Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.
    Gambrell RD; Maier RC; Sanders BI
    Obstet Gynecol; 1983 Oct; 62(4):435-43. PubMed ID: 6888821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on estrogens and uterine cancer.
    FDA Drug Bull; 1979; 9(1):2-3. PubMed ID: 428701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
    Berger GS; Fowler WC
    J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the progestogen challenge test to reduce the risk of endometrial cancer.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA; Wright JM
    Obstet Gynecol; 1980 Jun; 55(6):732-8. PubMed ID: 6446050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement estrogens and endometrial cancer.
    Jick H; Watkins RN; Hunter JR; Dinan BJ; Madsen S; Rothman KJ; Walker AM
    N Engl J Med; 1979 Feb; 300(5):218-22. PubMed ID: 759868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial cancer after menopausal use of estrogens.
    Greenwald P; Caputo TA; Wolfgang PE
    Obstet Gynecol; 1977 Aug; 50(2):239-43. PubMed ID: 876565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Cancer risk and estrogen use in the menopause.
    Ryan KJ
    N Engl J Med; 1975 Dec; 293(23):1199-200. PubMed ID: 1186792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous estrogens and development of breast and endometrial cancer.
    Vakil DV; Morgan RW; Halliday M
    Cancer Detect Prev; 1983; 6(4-5):415-24. PubMed ID: 6652636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer and the use of estrogens.
    Gambrell RD
    Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
    Zheng W; Xie D; Cerhan JR; Sellers TA; Wen W; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):89-94. PubMed ID: 11219777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen therapy: the dangerous road to Shangri-La.
    Consum Rep; 1976 Nov; 41(11):642-5. PubMed ID: 1028554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement treatment and breast cancer risk: an age-specific analysis.
    Tavani A; Braga C; La Vecchia C; Negri E; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):11-4. PubMed ID: 8993791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen regimen of women with endometrial carcinoma. A retrospective case-control study at Radiumhemmet.
    Obrink A; Bunne G; Collén J; Tjernberg B
    Acta Obstet Gynecol Scand; 1981; 60(2):191-7. PubMed ID: 7246086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.